Sonnet BioTherapeutics Holdings, Inc. (SONN)

NASDAQ: SONN · IEX Real-Time Price · USD
0.263
0.001 (0.34%)
May 27, 2022 12:02 PM EDT - Market open
Market Cap15.95M
Revenue (ttm)708,745
Net Income (ttm)-27.48M
Shares Out60.59M
EPS (ttm)-0.60
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume316,806
Open0.256
Previous Close0.262
Day's Range0.256 - 0.267
52-Week Range0.240 - 2.070
Beta0.36
AnalystsBuy
Price Target2.30 (+773.9%)
Earnings DateMay 16, 2022

About SONN

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-0...

IndustryBiotechnology
CEOPankaj Mohan
Employees9
Stock ExchangeNASDAQ
Ticker SymbolSONN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for SONN stock is "Buy." The 12-month stock price forecast is 2.3, which is an increase of 773.86% from the latest price.

Price Target
$2.3
(773.86% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update

IND for SON-1010 cleared by FDA with first patient dosed in trial for advanced solid tumors SON-080 on track to begin clinical studies by mid-2022 Preclinical data for SON-1010, SON-1210, and SON-1410 p...

2 weeks ago - Accesswire

Trending Penny Stocks to Buy This Month? 3 to Watch in April

Can these penny stocks continue to climb this month? The post Trending Penny Stocks to Buy This Month?

Other symbols:CEIIMPP
1 month ago - PennyStocks

Best Penny Stocks To Buy Now? 7 Stocks Under $1 With Big News Today

Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now?

1 month ago - PennyStocks

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors

PRINCETON, NJ / ACCESSWIRE / April 13, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that dosing has b...

1 month ago - Accesswire

Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American As...

PRINCETON, NJ / ACCESSWIRE / April 8, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that data from pre...

1 month ago - Accesswire

Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate

The FDA has signed off Sonnet BioTherapeutics Holdings Inc's (NASDAQ: SONN) Investigational New Drug (IND) application for SON-1010, a proprietary version of Interleukin 12 (IL-12) configured using Sonn...

2 months ago - Benzinga

Trading Penny Stocks? Top Stock Market News for March 16th, 2022

What you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for March 16th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...

Other symbols:DIDIVEON
2 months ago - PennyStocks

Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors

Represents Sonnet's first IND cleared Phase 1 trial initiation expected in 2Q22 PRINCETON, NJ / ACCESSWIRE / March 16, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Compan...

2 months ago - Accesswire

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting

PRINCETON, NJ / ACCESSWIRE / February 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs...

3 months ago - Accesswire

Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update

SON-1010 and SON-080 on track to initiate clinical studies during the second quarter of 2022 Completed R&D manufacturing for SON-1210 non-GLP toxicity study in non-human primates, with study initiation ...

3 months ago - Accesswire

Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update

PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drug...

5 months ago - Accesswire

Top Penny Stocks to Buy This Week? 3 You Need to Watch

With October off to a great start for penny stocks, which small-caps are you watching? The post Top Penny Stocks to Buy This Week?

Other symbols:SHIP
7 months ago - PennyStocks

Penny Stocks That Will Explode? Check These 3 Out For Your List

Check these three penny stocks out for your September watchlist The post Penny Stocks That Will Explode? Check These 3 Out For Your List appeared first on Penny Stocks to Buy, Picks, News and Informatio...

Other symbols:CEISESN
8 months ago - PennyStocks

Best Penny Stocks To Buy Under $1 Right Now? 5 To Watch In September

Red hot penny stocks to watch and YES all are under $1 right now. The post Best Penny Stocks To Buy Under $1 Right Now?

Other symbols:CEIHSTO
8 months ago - PennyStocks

See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday

​​​​​Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) stock is soaring during premarket in reaction to the selection of SON-1410 as a development candidate for melanoma and renal cancers. SON-1410 rep...

8 months ago - Benzinga

Sonnet Announces Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate (SON-1410)

SON-1410 (IL18-FHAB-IL12), a bispecific combination of Interleukins 18 and 12, was selected based on data generated in a mouse melanoma study comparing three bispecific constructs Selection of the asset...

8 months ago - Accesswire

Sonnet BioTherapeutics Stock Slumps After $30M Equity Raise

Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) priced the underwritten public offering of 35.3 million shares (including pre-funded warrants) and warrants to purchase up to 35.3 million shares.  Eac...

9 months ago - Benzinga

Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public Offering

PRINCETON, NJ / ACCESSWIRE / August 19, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs,...

9 months ago - Accesswire

Buying Penny Stocks Right Now? 3 to Watch in 2021

Looking to buy penny stocks in 2021? Check these 3 out for your list The post Buying Penny Stocks Right Now?

Other symbols:NLSPSENS
9 months ago - PennyStocks

SONN Stock: The Social Media Buzz Sending Sonnet Bio Rocketing Today

Sonnet BioTherapeutics (SONN) stock is taking off on Thursday and investors can thank retail traders on social media for pumping it higher. The post SONN Stock: The Social Media Buzz Sending Sonnet Bio ...

9 months ago - InvestorPlace

What's Happening With Sonnet BioTherapeutics Stock?

Trading of Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) stock was halted thrice during the early morning session. No company-specific reports are driving up the stock price today, so it appears th...

9 months ago - Benzinga

Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update

Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update Expanded F H AB Intellectual Property Portfolio  Completed $15.9 million At-The-Market Financing  SON-1010 and...

9 months ago - Accesswire

Sonnet BioTherapeutics Announces Change in Date of Annual Meeting

Annual Meeting to be Held Thursday July 15, 2021. PRINCETON, NJ / ACCESSWIRE / June 14, 2021 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a biopharmaceutical company developing innovative targ...

11 months ago - Accesswire

Sonnet BioTherapeutics Announces Issuance of U.S. Patent for Platform Technology

U.S. Patent and Trademark Office issued US Patent No. 11,028,166 for the Company's Fully Human Albumin Binding Domain Fusion Proteins PRINCETON, NJ / ACCESSWIRE / June 8, 2021 / Sonnet BioTherapeutics H...

11 months ago - Accesswire

Sonnet BioTherapeutics Provides Fiscal Year 2021 Second Quarter Business and Earnings Update

SON-1010, fully-human IL-12 configured using FHAB platform, advancing towards IND submission At-The-Market offering program resulted in net proceeds of $10.2 million PRINCETON, NJ / ACCESSWIRE / May 17,...

1 year ago - Accesswire